Bfri Forum (2024)

FAQs

Is BFRI stock a good buy? ›

Biofrontera has 1140.31% upside potential, based on the analysts' average price target. Is BFRI a Buy, Sell or Hold? Biofrontera has a conensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.

Biofrontera has 5.09 million shares outstanding. The number of shares has increased by 171.44% in one year.

Biofrontera Inc. stock prediction for 2030: $ 15.81 (829.96%)

The average price target for Codex DNA is $5.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $5.00 ,the lowest forecast is $5.00.

PINS Stock 12 Month Forecast

Based on 21 Wall Street analysts offering 12 month price targets for Pinterest in the last 3 months. The average price target is $46.17 with a high forecast of $52.00 and a low forecast of $38.00.

24 analysts offering 12-month price forecasts for Juniper Networks, Inc. (JNPR) have a share price target of $39.91.

JOANN's analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Streets Analysts.

Is AbSci a good buy? ›

Based on analyst ratings, AbSci's 12-month average price target is $8.75. AbSci has 80.04% upside potential, based on the analysts' average price target. AbSci has a conensus rating of Strong Buy which is based on 4 buy ratings, 1 hold ratings and 0 sell ratings. The average price target for AbSci is $8.75.

MPWR Stock Forecast FAQ

Monolithic Power has 3.38% upside potential, based on the analysts' average price target. Is MPWR a Buy, Sell or Hold? Monolithic Power has a conensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings. What is Monolithic Power's price target?

The financial health and growth prospects of BFRI, demonstrate its potential to underperform the market. It currently has a Growth Score of D. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of A.

A portfolio of 10 or more stocks, particularly those across various sectors or industries, is much less risky than a portfolio of only two stocks.

Based on 18 Wall Street analysts offering 12 month price targets for Foot Locker in the last 3 months. The average price target is $24.34 with a high forecast of $32.00 and a low forecast of $17.00. The average price target represents a 9.05% change from the last price of $22.32.

Maravai Lifesciences Holdings's analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.

BRFS is currently sporting a Zacks Rank of #1 (Strong Buy) and an A for Value. We should also highlight that BRFS has a P/B ratio of 1.25. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities.

JOANN stock has received a consensus rating of buy. The average rating score is and is based on 14 buy ratings, 12 hold ratings, and 2 sell ratings. What was the 52-week low for JOANN stock? The low in the last 52 weeks of JOANN stock was 0.05.